Two biotech stocks, Ligand Pharmaceuticals and United Therapeutics, are showing resilient action in Friday's stock market.

Moderna's full pipeline may fuel long-term growth.

The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...

Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for biotech companies.

This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance ...

Jefferies has identified its top picks in the small and mid-cap (SMID) biotechnology sector, highlighting three companies ...

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical ...

Biotech investors have rarely united so strongly against a Food and Drug Administration official as they did against Vinay ...

The biotech sector is one that's become red-hot, at least in recent years. After around a decade of stagnation, investors appear to be intent on increasing their exposure to top biotech names in the ...

Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...